Nick Oliver

Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups

Nathan R. Hill, Nick Oliver, Pratik Choudhary et al. · Diabetes Technology & Therapeutics · 2011 · 365 citations

Medicine, Endocrinology, Internal Medicine +17

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 347 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial

Ambady Ramachandran, Chamukuttan Snehalatha, Ram Jagannathan et al. · The Lancet Diabetes & Endocrinology · 2013 · 346 citations

Medicine, Health Promotion, Preventive Medicine +14

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

Monika Reddy, Narvada Jugnee, E. Spanudakis et al. · Diabetic Medicine · 2017 · 244 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +15

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

Othmar Moser, Michael C. Riddell, Max L. Eckstein et al. · Diabetologia · 2020 · 207 citations · Full text

Medicine, Endocrinology, Pediatrics +17